Graffinity Pharmaceuticals GmbH
Im Neuenheimer Feld 518
Heidelberg
69120
Germany
Tel: 49-0-6221-65100
Fax: 49-0-6221-65101-11
Website: http://www.graffinity.com/
Email: contact@graffinity.com
8 articles about Graffinity Pharmaceuticals GmbH
-
Graffinity Pharmaceuticals GmbH Enters into Drug Discovery Collaboration with Shionogi & Co., Ltd.
3/30/2011
-
NovAliX Acquires a Majority Interest in Graffinity Pharmaceuticals GmbH
11/16/2010
-
Graffinity Pharmaceuticals GmbH Enters into Drug Discovery Research Collaboration with Genentech (South SF)
10/15/2009
-
Graffinity Pharmaceuticals GmbH And Elan Corporation PLC Launch Fragment-Based Drug Discovery Collaboration
1/26/2009
-
Graffinity Pharmaceuticals GmbH And AstraZeneca Pharmaceuticals LP Enter Into Multi-Target Drug Discovery Alliance
10/28/2008
-
Graffinity Pharmaceuticals GmbH And Amgen Enter into Drug Discovery Research Agreement
2/26/2007
-
Boehringer Ingelheim Pharmaceuticals, Inc. Expands Drug Discovery Alliance With Graffinity Pharmaceuticals GmbH
12/13/2006
-
Graffinity Pharmaceuticals GmbH And Boehringer Ingelheim Pharmaceuticals, Inc. Enter Into Drug Discovery Research Agreement
9/7/2006